I remain optimistic that the worm will turn Wednes
Post# of 144904
Plenty of room in Covid for therapeutics even if a vaccine and anti-viral prove effective.
I would loose to see Biocryst succeed. Galidesevir appears to be a nucleotide analog that actually works.
It’s success would be the biggest direct kick to Gilead until Cytodyn steals the Gilead market share for HIV.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)